ENTERA BIO LTD. Depreciation
ENTERA BIO LTD. (ENTX) reported Depreciation of $16.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-07
- ENTERA BIO LTD. depreciation for the quarter ending 2026-06-30 was $9.00K, a 28.57% increase year-over-year.
- ENTERA BIO LTD. depreciation for the quarter ending 2026-03-31 was $7.00K, a 12.50% decline year-over-year.
- ENTERA BIO LTD. depreciation for the quarter ending 2025-12-31 was $7.00K, a 36.36% decline year-over-year.
- ENTERA BIO LTD. depreciation for the quarter ending 2025-09-30 was $8.00K, a 27.27% decline year-over-year.
- ENTERA BIO LTD. depreciation for fiscal 2025 was $30.00K, a 34.78% decline from fiscal 2024.
- ENTERA BIO LTD. depreciation for fiscal 2024 was $46.00K, a 17.86% decline from fiscal 2023.
- ENTERA BIO LTD. depreciation for fiscal 2023 was $56.00K, a 12.50% decline from fiscal 2022.
- ENTERA BIO LTD. depreciation for fiscal 2022 was $64.00K, a 20.75% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $16.00K 10-Q · filed 2026-08-07 | $23.00K derived: sum of 3 quarters · filed 2026-08-07 | $31.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $7.00K 10-Q · filed 2026-05-08 | $14.00K derived: sum of 2 quarters · filed 2026-05-08 | $22.00K derived: sum of 3 quarters · filed 2026-05-08 | $29.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $15.00K derived: sum of 2 quarters · filed 2026-03-27 | $22.00K derived: sum of 3 quarters · filed 2026-08-07 | $30.00K 10-K · filed 2026-03-27 |
| 2025-09-30 | $8.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $15.00K derived: sum of 2 quarters · filed 2026-08-07 | $23.00K 10-Q · filed 2025-11-14 | $34.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $7.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $15.00K 10-Q · filed 2026-08-07 | $26.00K derived: sum of 3 quarters · filed 2026-08-07 | $37.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $8.00K 10-Q · filed 2026-05-08 | $19.00K derived: sum of 2 quarters · filed 2026-05-08 | $30.00K derived: sum of 3 quarters · filed 2026-05-08 | $41.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $22.00K derived: sum of 2 quarters · filed 2026-03-27 | $33.00K derived: sum of 3 quarters · filed 2026-03-27 | $46.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $22.00K derived: sum of 2 quarters · filed 2025-11-14 | $35.00K 10-Q · filed 2025-11-14 | $48.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | $11.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $24.00K 10-Q · filed 2025-08-08 | $37.00K derived: sum of 3 quarters · filed 2025-08-08 | $51.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | $13.00K 10-Q · filed 2025-05-09 | $26.00K derived: sum of 2 quarters · filed 2025-05-09 | $40.00K derived: sum of 3 quarters · filed 2025-05-09 | $55.00K derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $27.00K derived: sum of 2 quarters · filed 2025-03-28 | $42.00K derived: sum of 3 quarters · filed 2025-03-28 | $56.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $29.00K derived: sum of 2 quarters · filed 2024-11-08 | $43.00K 10-Q · filed 2024-11-08 | $59.00K derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $29.00K 10-Q · filed 2024-08-09 | $45.00K derived: sum of 3 quarters · filed 2024-08-09 | $61.00K derived: sum of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | $14.00K 10-Q · filed 2024-05-10 | $30.00K derived: sum of 2 quarters · filed 2024-05-10 | $46.00K derived: sum of 3 quarters · filed 2024-05-10 | $62.00K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $32.00K derived: sum of 2 quarters · filed 2024-03-08 | $48.00K derived: sum of 3 quarters · filed 2024-03-08 | $64.00K 10-K · filed 2024-03-08 |
| 2022-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $32.00K derived: sum of 2 quarters · filed 2023-11-14 | $48.00K 10-Q · filed 2023-11-14 | $62.00K derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $32.00K 10-Q · filed 2023-08-11 | $46.00K derived: sum of 3 quarters · filed 2023-08-11 | $61.00K derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $16.00K 10-Q · filed 2023-05-05 | $30.00K derived: sum of 2 quarters · filed 2023-05-05 | $45.00K derived: sum of 3 quarters · filed 2023-05-05 | $60.00K derived: sum of 4 quarters · filed 2023-05-05 |
| 2021-12-31 | $14.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $29.00K derived: sum of 2 quarters · filed 2023-03-31 | $44.00K derived: sum of 3 quarters · filed 2023-03-31 | $53.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $30.00K derived: sum of 2 quarters · filed 2022-11-10 | $39.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $15.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $24.00K 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $9.00K 10-Q · filed 2022-05-12 | |||
| 2020-12-31 | $63.00K 10-K · filed 2022-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |